The hidden effects of antihypertensive and lipid-lowering agents on the prevention and regression of atherogenesis: new management strategies.
作者信息
Weinberg M S
机构信息
Roger Williams Medical Center, USA.
出版信息
R I Med. 1995 Mar;78(3):78-81.
PMID:7734758
Abstract
摘要
相似文献
1
2
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
J Hum Hypertens. 2003 Jun;17(6):367-72. doi: 10.1038/sj.jhh.1001556.
3
Antihypertensive and lipid lowering treatment in stroke prevention: current state and future.预防卒中的降压和降脂治疗：现状与未来
Acta Neurol Belg. 2005 Jun;105(2):57-61.
4
Taking risks: primary prevention of cardiovascular events.
N Z Med J. 2001 May 25;114(1132):223-4.
5
ALLHAT: a saga of missed opportunities.
J Hum Hypertens. 2003 Jun;17(6):373-7. doi: 10.1038/sj.jhh.1001564.
6
Basic approach to managing hyperglycemia for the nonendocrinologist.非内分泌科医生管理高血糖的基本方法。
Am J Cardiol. 2005 Aug 22;96(4A):37E-40E. doi: 10.1016/j.amjcard.2005.06.003.
7
8
Coronary revascularization and aggressive lipid lowering.冠状动脉血运重建和强化降脂治疗。
J Invasive Cardiol. 1999 Feb;11(2):87-9.
9
[How can primary prevention of coronary heart disease be improved in general practice?].在全科医疗中如何改善冠心病的一级预防？
Med Klin (Munich). 1994 Apr 15;89(4):184-6, 229.
10
Prevention and treatment of arteriosclerosis.动脉硬化的预防与治疗。
Compr Ther. 1992 Feb;18(2):30-2.
Zotero 插件